Bookmark
Print
Send to a friend
Home » Resources » Publications
Publications
2014
184
Regulatory Issues related to preclinical animal research.
ELENA PP (a)
ARVO meeting 2014; Orlando, FL - USA. Oral communication.
(a) IRIS PHARMA, Nice, France
 
183
Plasma and ocular pharmacokinetic study comparing 3 µL micro-drop to typical 40 µL drop volume of timolol 0.5% in pigmented rabbits.
VAN DER HEIDEN H (a,b)AMAR T (c), LICHTENAUEUR W (a)
ARVO meeting 2014; Orlando, FL - USA. ARVO e-abstract No. 453 - Poster D0072.
(a) MU-DROP, Apeldoorn, Netherlands - (b) ZAMB, Hospital Pharmacy, Tilburg, Netherlands  - (c) IRIS PHARMA, Nice, France
 
182
Ocular Pharmacokinetic Study Comparing Ramipril and Ramiprilat Formulations Administered Orally or Topically in Pigmented Rabbits.
QUENTRIC Y (a), AMAR T (a), BARRE N (a)FERAILLE L (a), REKIK R (b)
ARVO meeting 2014; Orlando, FL - USA. ARVO e-abstract No. 2360 - Poster B0036.
(a) IRIS PHARMA, Nice, France - (b) OPHTHALMOLOGY CLINIC, Tunis, Tunisia

181
Safety and Tolerability of Drugs Within the Suprachoroidal Space in Albino Rabbits.
PATEL S (a), VERHOEVEN R (a), BURKE B (a), CACCIAMANI F (b), VIAUD-QUENTRIC K (b), EDELHAUSER H (c,a)
ARVO meeting 2014; Orlando, FL - USA. ARVO e-abstract No. 4886 - Poster C0082. 
(a) CLEARSIDE BIOMEDICAL, Alpharetta, GA, USA - (b) IRIS PHARMA, Nice, France - (c) EMORY UNIV EYE CENTER, Atlanta, GA, USA

180
Biocompatibility of MedinGel biodegradable drug delivery system in the eye.
SPIS M (a), FERAILLE L (b)ANTONELLI S (b), CIMBOLINI N (b),  ELENA PP (b),  GAUDRIAULT G (a), PETIT A (a)
ARVO meeting 2014; Orlando, FL - USA. ARVO e-abstract No. 5273 - Poster C0069. 
(a) MEDINCELL, Jacou, France - (b) IRIS PHARMA, Nice, France

2013
179
Dry eye: two experimental rodent models for drug development.
CIMBOLINI N (a), ANTONELLI S (a), BARABINO S (b), FERAILLE L (a), MARGARON P (a), ELENA PP (a)
TFOS meeting 2013; Taormina - Sicily - Italy.
(a) IRIS PHARMA, Nice, France - (b) CLINICA OCULISTICA, Genova, Italy
 
178
Effects of cyclosporine in an experimental rat model of dry eye.
CIMBOLINI N (a), ANTONELLI S (a), FERAILLE L (a), MARGARON P (a), ELENA PP (a).
EVER meeting 2013; Nice – France. Poster S008. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France

177
Impact of the routes of administration on the effects of cyclosporine in an experimental rat model of dry eye.
CIMBOLINI N (a), GRILLO-ANTONELLI S (a), FERAILLE L (a), MARGARON P (a), ELENA PP (a).
ISOPT meeting 2013; Paris – France.
(a) IRIS PHARMA, Nice, France

176
Suprachoroidal Microinjection of Triamcinolone Acetonide is Well Tolerated in the Albino Rabbit.
VERHOEVEN R (a), PATEL S (a),  VIAUD-QUENTRIC K (b), CACCIAMANI F (b), AMAR T (b), YERXA B (a).
ARVO meeting 2013; Seattle, WA - USA. ARVO e-abstract No. 119 - Poster C0124. ⇒ to read the abstract
(a) CLEARSIDE BIOMEDICAL, Alpharetta, GA, USA
(b) IRIS PHARMA, Nice, France

175
Comparison of two rodent models of dry eye induced by Scopolamine.
ELENA PP (a), CIMBOLINI N (a), ANTONELLI S (a), FERAILLE L (a), BARABINO S (b), MARGARON P (a).
ARVO meeting 2013; Seattle, WA - USA. ARVO e-abstract No. 6002 - Poster A0065. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France - (b) CLINICA OCULISTICA, Genova, Italy

2012
174
Report of the TFOS/ARVO Symposium on Global Treatments for Dry Eye Disease: An Unmet Need.
SULLIVAN D (a), HAMMITT K (b), SCHAUMBERG D (c), SULLIVAN B (d), BEGLEY C (e), GJORSTRUP P (f), GARRIGUE JS (g), NAKAMURA M (h), QUENTRIC Y (i), BARABINO S (j), DALTON M (k) and NOVACK G (l).
The Ocular Surface. Special Article. April 2012; 10(2): 108-116. ⇒ to read the abstract
(a) SCHEPENS EYE RESEARCH INSTITUTE, Boston, MA, USA - (b) SJOGREN’s SYNDROME FOUNDATION, Bethesda, MD, USA - (c) BRIGHAM AND WOMEN'S HOSPITAL and HARVARD MEDICAL SCHOOL, Boston, MA, USA - (d) TEARLAB Corporation, San Diego, CA, USA - (e) SCHOOL OF OPTOMETRY, Bloomington, IN, USA - (f) RESOLVYX PHARMACEUTICALS, Bedford, MA, USA - (g) NOVAGALI PHARMA, Evry, France - (h) SANTEN PHARMACEUTICAL Co, Nara, Japan - (i) IRIS PHARMA, Nice, France - (j) CLINICA OCULISTICA, Genova, Italy - (k) DALTON & ASSOCIATES, Reading, PA, USA - (l) PHARMA LOGIC, San Rafael, CA, USA

173
Assessment of a New Device for Conjunctival Impression.
ROY P (a), CIMBOLINI N (b), ANTONELLI S (b), FERAILLE L (b), ELENA PP (b) and BAUDOUIN C (c).
MCLOSA meeting 2012; London - England.
(a) OPIA TECHNOLOGIES, Paris, France - (b) IRIS PHARMA, Nice, France - (c) Ophthalmology, Quinze-Vingts Hospital, Paris, France

172
Protection of blue light induced retinal degeneration by the free radical scavenger Phenyl-N-tert-butylnitrone and a serotonin receptor 5-HT1a agonist in rats.
GRILLO-ANTONELLI S (a), CIMBOLINI N (a), DUBOS H (a), FERAILLE L (a), MARGARON P (a) and ELENA PP (a).
EVER meeting 2012; Nice - France. Poster S063. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France

171
Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping.
DAULL P (a), FERAILLE L (b), ELENA PP (b), BAUDOUIN C (c) and GARRIGUE JS (a).
EVER meeting 2012; Nice - France. Poster T036. ⇒ to read the abstract
(a) NOVAGALI PHARMA SA, Evry, France - (b) IRIS PHARMA, Nice, France - (c) INSTITUT DE LA VISION, Paris, France

170
Ocular surface effects of antiglaucoma combination therapies in a rat model of corneal scraping.
DAULL P (a), GARRIGUE JS (a), FERAILLE L (b), BAUDOUIN C (c) and ELENA PP (b).
EVER meeting 2012; Nice - France. Poster T037 . ⇒ to read the abstract
(a) NOVAGALI PHARMA SA, Evry, France - (b) IRIS PHARMA, Nice, France - (c) INSTITUT DE LA VISION, Paris, France

169
Multiple topical administrations of Ramipril enhance retinal ganglion cell survival after transient retinal ischemia-reperfusion in rats.
ELENA PP (a), VIAUD-QUENTRIC K (a), CHARFEDDINE R (b) and REKIK R (c).
EVER meeting 2012; Nice - France. Poster F029. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France - (b) UNIMED, Sousse, Tunisie - (c) Ophthalmology Clinic, Tunis, Tunisia

168
Augmentation of the ocular penetration of dexamethasone with β-blocker and α-agonist co-administration.
ELENA PP (a), SENSEBY F (a), BERMON F (a), CHARFEDDINE R (b) and REKIK R (c).
EVER meeting 2012; Nice - France. Poster F107. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France - (b) UNIMED, Sousse, Tunisie - (c) Ophthalmology Clinic, Tunis, Tunisia

167
Anti-inflammatory Effects Of Glucocorticoids On Endotoxin-induced Uveitis In Rats: Effects Of The Mode Of Administration.
ELENA PP (a), CIMBOLINI N (a), ANTONELLI S (a), DUBOS H (a), FERAILLE L (a) and MARGARON P (a).
ARVO meeting 2012; Fort Lauderdale, FL - USA. ARVO e-abstract No. 6285 - Poster D1145. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France

166
Assessment of Intra-Ocular Pressure lowering effect of novel gel formulations of Latanoprost and Timolol in nonhuman primates following topical delivery.
GOODY RJ (a), WHITTAKER S (a), HENRY S (a), BROOKES R (a), STRUHARIK M (a), BERMON F (b), MARGARON P (b), POLZER H (c), LAWRENCE MS (a).
ARVO meeting 2012; Fort Lauderdale, FL - USA. ARVO e-abstract No. 1968 - Poster D812. ⇒ to read the abstract
(a) RXGEN, Hamden, CT, USA - (b) IRIS PHARMA, Nice, France - (c) MEDPROJECT PHARMA, Bayern, Germany

165
Assessment of a New Device for Conjunctival Impression.
ROY P (a), CIMBOLINI N (b), ANTONELLI S (b), FERAILLE L (b) ELENA PP (b) and BAUDOUIN C (c).
ARVO meeting 2012; Fort Lauderdale, FL - USA. ARVO e-abstract No. 1868 - Poster A331. ⇒ to read the abstract
(a) OPIA TECHNOLOGIES, Paris, France - (b) IRIS PHARMA, Nice, France - (c) Ophthalmology, Quinze-Vingts Hospital, Paris, France

2011
164
Assessment of a New Device for Conjunctival Impression.
ROY P (a), CIMBOLINI N (b), ANTONELLI S (b), FERAILLE L (b) and ELENA PP (b).
Oral presentation. ISOPT meeting 2011; Vienna, Austria.
(a) OPIA TECHNOLOGIES, Paris, France - (b) IRIS PHARMA, Nice, France

163
Explorations et imagerie rétinienne.
BENCHABOUNE M (a).
STO meeting 2011; Tunis - Tunisia. Oral Communication in French.
(a) IRIS PHARMA, Nice, France

162
Adaptative optics imaging in age-related macular degeneration.
GOCHO-NAKASHIMA K (a), BENCHABOUNE M (b), ULLERN M (a), LAMORY B (c) , CHATEAU N (c) , SAHEL JA (a), PAQUES M (a).
EVER meeting 2011; Crete - Greece. Oral Communication. ⇒ to read the abstract
(a) INSERM 503, Paris, France - (b) IRIS PHARMA, Nice, France - (c) IMAGINE EYES, Orsay, France

161
In vivo microscopic imaging of drusen using adaptive optics.
LAMORY B (a), NAKASHIMA K (b), BENCHABOUNE M (b,c), ULLERN M (b), VUAILLAT E (a), SAHEL JA (b) and PAQUES M (b).
ARVO meeting 2011; Fort Lauderdale, FL - USA. ARVO e-abstract No. 4469/A218. ⇒ to read the abstract
(a) IMAGINE EYES, Orsay, France - (b) INSERM 503, Paris, France - (c) IRIS PHARMA, Nice, France
 
160
Evaluation of Membrane Material for Impression Cytology.
ROY P (a), CIMBOLINI N (b), FERAILLE L (b), KECHAD M (b) and ELENA PP (b).
ARVO meeting 2011; Fort Lauderdale, FL - USA. ARVO e-abstract No. 1937 - Poster D918. ⇒ to read the abstract
(a) OPIA TECHNOLOGIES, Paris, France - (b) IRIS PHARMA, Nice, France

2010
159
Ocular Distribution and Spectrum of Activity of a Fully Human Anti-Herpes Simplex Virus IgG Fab Fragment, Following Topical Application.
BERDUGO-POLAK M (a,b), LARSEN IV (c), ABADIE C (d), KOWALCZUK L (a,b), TOUCHARD E (a,b), NELSON JD (e), ELENA PP (f), BRANDT CR (c), BEHAR-COHEN F (a,b,g), COMBETTE JM (d).
ARVO meeting 2010; Fort Lauderdale, FL - USA. ARVO e-abstract No. 1991 - Poster D1028. ⇒ to read the abstract
(a) INSERM UMRS 872, Paris, France - (b) Pierre et Marie Curie University, Paris, France - (c) University of Wisconsin School of Medicine and Public Health, Madison, WI, USA - (d) RIBOVAX BIOTECHNOLOGIES, Petit-Lancy, Switzerland - (e) CALMUNE CORPORATION, San Diego, CA, USA - (f) IRIS PHARMA, Nice, France - (g) Hotel-Dieu University Hospital, Paris, France

158
Dry Eye Syndrome : the regulatory challenge. Clinical trial and regulatory challenges faced by Iris Pharma in the development of dry eye therapies.
QUENTRIC Y (a).
TFOS Global Dry Eye Experts' meeting 2010; Florence - Italy. Oral Communication.
(a) IRIS PHARMA, Nice, France

157
Rôle des oligoéléments (Se, Zn) dans la prévention de la DMLA : le point en 2010.
BENCHABOUNE M (a).
SFVB/SFERETE/ATERET meeting 2010; Monastir - Tunisia. Oral Communication in French.
(a) IRIS PHARMA, Nice, France

156
Designing dendrimers for ocular delivery.
SPATARO G (a,b), MALECAZE F (c), TURRIN CO (a,b), SOLER V (c), DUHAYON C(a,b), ELENA PP (d), MAJORAL JP (a,b), and CAMINADE AM (a,b).
Eur. J. Med. Chem. 2010; 45: 326-334. ⇒ to read the abstract
(a) CNRS, Laboratoire de Chimie de Coordination, Toulouse, France - (b) Universite de Toulouse, Toulouse, France -  (c) Hôpital Purpan, Toulouse, France - (d) IRIS PHARMA, Nice, France

2009
155
Ocular Surface Distribution and Pharmacokinetics of a Novel Ophthalmic 1% Azithromycin Formulation.
AKPEK EK (a), VITTITOW J (b), VERHOEVEN RS (b), BRUBAKER K (b), AMAR T (c), POWELL KD (d), BOYER JL (b), and CREAN C (b).
J. Ocul. Pharmacol. Ther. 2009; 25: 433-439. ⇒ to read the abstract
(a) THE WILMER EYE INSTITUTE, Johns Hopkins Hospital, Baltimore, USA - (b) INSPIRE PHARMACEUTICALS, Durham, USA - (c) IRIS PHARMA, Nice, France - (d) ENTHALPY ANALYTICAL, Durham, USA

154
Associer les patients atteints de DMLA à la recherche, est-ce possible?
BENCHABOUNE M (a).
Vu et Entendu. 2009; 2: 4. ⇒ to read the article
(a) IRIS PHARMA, Nice, France

153
Corneal Effect of Topical Diclofenac co-Administration with Aminoside and Steroid in Rabbits.
CAILLAUD T (a), VIAUD K (a), and ELENA PP (a).
ARVO meeting 2009; Fort Lauderdale, FL - USA. ARVO e-abstract No. 1957.
(a) IRIS PHARMA, Nice, France

152
Snapshot Test for Investigating Gels of Anti-Glaucoma Compounds as Topical Formulations.
ELENA PP (a), POLLIN C (a), BERMON F (a), AMAR T (a), CAILLAUD T (a), and POLZER H (b).
ARVO meeting 2009; Fort Lauderdale, FL - USA. ARVO e-abstract No. 6002.
(a) IRIS PHARMA, Nice, France - (b) MEDPROJECT PHARMA, Bayern, Germany

2008
151
Ocular Pharmacokinetic Study Following Single and Multiple Azithromycin Administrations in Pigmented Rabbits.
AMAR T (a), CAILLAUD T (a), and ELENA PP (a).
Curr Eye Res. 2008; 33: 149-158. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France

150
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers.
CHIAMBARETTA F, GARRAFFO R, ELENA PP, POULIQUEN P, DELVAL L, RIGAL D, DUBRAY C, GOLDSCHMIDT P, TABBARA K and COCHEREAU I.
Eur. J. Ophthalmol. 2008; 18(1): 13-20. ⇒ to read the abstract

149
La recherche biomédicale en France : ce qui a changé depuis 2004.
CLERGET-CHOSSAT N(a), CAILLAUD T (a), and ELENA PP (a).
J. Fr. Ophtalmol. 2008; 31: 80-86. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France

148
Immunohistochemistry and in situ Zymography to Assess Matrix Metalloproteinases Expression and Activation by Latanoprost in Rat Uveoscleral Pathway.
ELENA PP (a), FRETON A (a), SPADAFORA A (a), GRILLO-ANTONELLI S (a), CIMBOLINI N (a), FERAILLE L (a), and LAZDUNSKI M (b).
ARVO meeting 2008; Fort Lauderdale, FL - USA. ARVO e-abstract No. 2616.
(a) IRIS PHARMA, Nice, France - (b) IPMC-UMR 6097, Valbonne, France

2007
147
Cationic Oil-in-Water Emulsion as an Improved Cyclosporine Ocular Vehicle for Vernal Keratoconjuctivitis Sicca (VKC).
LAMBERT G (a), RABINOVICH-GUILATT L (a).
ARVO meeting 2007; Fort Lauderdale, FL - USA. ARVO poster No. 2301/B999 (collaboration).
(a) NOVAGALI PHARMA SA, Evry, France

146
Ocular Tolerability of Iontophoresis.
ROY P (a), ELENA PP (b), VIAUD K (b), CAILLAUD T (b), AND CALIAS P.
ARVO meeting 2007; Fort Lauderdale, FL - USA. ARVO e-abstract No. 5800.
(a) EYEGATE PHARMACEUTICALS, Waltham, USA - (b) IRIS PHARMA, Nice, France

145
New evaluation techniques in ocular surface diseases : comparison of antiallergic drugs using in vivo confocal microscopy for assessing late response of induced ocular anaphylaxis in the guinea pig. 
FERAILLE L (a).
Oral presentation. EVER meeting 2007; Portoroz, Slovenia.
(a) IRIS PHARMA, Nice, France

144
Update on Drug Delivery Systems Used in the Anterior Part of the Eye : review of the new drug delivery systems for the anterior chamber.
ELENA PP (a).
Oral presentation. ESCRS meeting 2007; Stockholm, Sweden.
(a) IRIS PHARMA, Nice, France

143
Trend of prescription of silicon hydrogel lens by ophthalomologists and lens assessment by patients.
CROS BOIDEVEZI M (a), STEVE L (a), JOUVENCEL R (a),CLIROPHTHA (b).
29th IEEE EMBS Annual International Conference 2007; Lyon - France.
(a) CIBA VISION France, Paris, France - (b) CLIROPHTHA, Nice, France

142
A new method for intra ocular pressure in vivo measurement: first clinical trials.
DUBOIS P, ZEMMOURI J, ROULAND JF, ELENA PP, LOPES R, PUECH P.
29th IEEE EMBS Annual International Conference 2007; Lyon - France.
 
141
Histoire des essais cliniques : aspects scientifiques, éthiques et juridiques.
WYDAUW E (a), MAILLOLS-PERROY AC (b).
(Thesis - in French) ⇒ more information
(a) IRIS PHARMA, Nice, France - (b) UNIVERSITE DU DROIT ET DE LA SANTÉ, Lille, France

140
In vivo characterization of the anti-inflammatory effect of a multikinase inhibitor targeting angiogenesis and inflammation.
JENSEN L (a), HJARNAA P (a), FENSHOLDT J (a), ELENA PP (b), ABELL K (a) and PETERSEN TK (a).
8th World Congress on Inflammation 2007; Copenhagen, Denmark. Inflamm Res. 2007; 56(suppl.3): S443, abstract P07.21. ⇒ to read the abstract
(a) LEO PHARMA, Ballerup, Denmark - (b) IRIS PHARMA, Nice, France 
 
2006
139
The role of the CROs in the ophthalmological drug development in Europe.
ELENA PP (a).
Oral presentation. ISOPT meeting 2006; Berlin, Germany. ⇒ to read the abstract  ⇒ to download the presentation
(a) IRIS PHARMA, Nice, France 
 
138
Improvement of dry eye symptoms with polyunsaturated fatty acids.
GARCHER C, PASSEMARD M, LAFONTAINE PO, VIAU S, JOFFRE C, ELENA PP, POULIQUEN P, BAUDOUIN C and BRON AM.
Acta Ophthalmologica Scandinavica. 2006; 84 Supplement 239: 135.
 
137
Amélioration de la symptomatologie chez des patients atteints de sécheresse oculaire et traités oralement par des acides gras polyinsaturés. Improvement of dry eye symptoms with polyunsaturated fatty acids.
GARCHER C, PASSEMARD M, VIAU S, JOFFRE C, LAFONTAINE PO, ELENA PP, POULIQUEN P, BAUDOUIN C and BRON AM.
SFO meeting 2006; Paris - France. Oral communication No. 220.
 
136
Enquête prospective, nationale, multicentrique auprès de 345 patients anciens et nouveaux porteurs sur la santé oculaire, la performance visuelle et la satisfaction des lentilles 02 OPTIX TORIC.
DELFOUR-MALECAZE M (a), STEVE L (b), CLIROPHTHA (c).
Réflexions Ophtalmol. 2006; 95: 50-53.
(a) Toulouse, France (b) CIBA VISION France, Paris, France - (c) CLIROPHTHA, Nice, France

135
Improvement of dry eye symptoms with polyunsaturated fatty acids.
CREUZOT C, PASSEMARD M, VIAU S, JOFFRE C, POULIQUEN P, ELENA PP, BRON A and BRIGNOLE F.
J. Fr. Ophtalmol. 2006; 29(8): 868-73. ⇒ to read the article
 
134
Trend of prescription of silicon hydrogel lens by ophthalomologists and lens assessment by patients.
CROS BOIDEVEZI M (a), STEVE L (a), JOUVENCEL R (a), CLIROPHTHA (b).
36th ECLSO Congress 2006; Dubrovnik - Czech Republic. Abstract No. 9. ⇒ to read the abstract
(a) CIBA VISION France, Paris, France - (b) CLIROPHTHA, Nice, France

133
Etude comparative des implants Alcon asphériques (SN60WF) versus standards (SN60AT).
MONTARD M.
Safir meeting 2006. Paris - France (collaboration).
 
132
Improvement of dry eye symptoms with polyunsaturated fatty acids.
GARCHER C (a), PASSEMARD M (a), LAFONTAINE PO (a), VIAU S (b), JOFFRE C (b), ELENA PP (c), POULIQUEN P (d), BAUDOUIN C (e) and BRON AM (a).
EVER meeting 2006; Vilamoura - Portugal, free paper No. 3155 and poster No. 335. ⇒ to read the abstract
(a) Hopital General, Dijon, France - (b) INRA - Eye and Nutrition Unit, Dijon, France (c) CLIROPHTHA, Nice, France (d) LABORATOIRES THEA, Clermont-Ferrand, France - (e) CHNO XV-XX, Paris, France

131 Improvement of dry eye symptoms with polyunsaturated fatty acids.
GARCHER C, PASSEMARD M, LAFONTAINE PO, VIAU S, JOFFRE C, ELENA PP, POULIQUEN P, BAUDOUIN C and BRON AM.
ARVO meeting 2006; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2006; 47: ARVO e-abstract No. 236.
 
130
Pharmacokinetics of clonidine after a single application of transscleral iontophoresis in rabbits.
CAILLAUD T (a), ROY P (b), VIAUD K (a) AND ELENA PP (a).
ARVO meeting 2006; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2006; 47: ARVO e-abstract No. 5109.
(a) IRIS PHARMA, Nice, France - (b) EYEGATE, Paris, France

129
Influence of Solution Composition and Electrode Design on Transscleral Iontophoresis Delivery of Dexamethasone Disodium Phosphate.
ROY P (a), VIAUD K (b), CAILLAUD T (b), AND ELENA PP (b).
ARVO meeting 2006; Fort Lauderdale, FL - USA. ARVO e-abstract No. 5110.
(a) EYEGATE, Paris, France - (b) IRIS PHARMA, Nice, France 
 
128
Evaluation of Ocular Tolerability of Repetitive Corneal-Scleral Iontophoresis in Pigmented Rabbits.
ELENA PP (a), ROY P (b), VIAUD K (a) AND CAILLAUD T (a).
ARVO meeting 2006; Fort Lauderdale, FL - USA. ARVO e-abstract No. 5094.
(a) IRIS PHARMA, Nice, France - (b) EYEGATE, Paris, France

127
Effects of Dexamethasone in a Rat model of choroidal neovascularization.
FERAILLE L (a), GRILLO-ANTONELLI S (a), CIMBOLINI N (a), CAILLAUD T (a), AND ELENA PP (a).
Ocular Anti-Angiogenesis meeting 2006; London - United Kingdom. ⇒ to see the poster
(a) IRIS PHARMA, Nice, France
 
2005
126
Variation of Krüppel-like factors levels in mouse corneal model of angiogenesis.
CHIAMBARETTA F, DE GRAEVE F, FERAILLE L, NEZZAR H, MARCEAU G, DASTUGNE B, RIGAL D, ELENA PP AND SAPIN V.
ARVO meeting 2005; Fort Lauderdale, FL. Invest. Ophthalmol. Vis. Sci. 2005; 46: ARVO e-abstract No. 2609.
 
125
Regard® : une enquête sur la tolérance et le confort oculaire d'une solution d'entretien pour lentilles de contact sans conservateur.
MALET F, CLIROPHTHA.
Réflexions Ophtalmol. 2005; 84: 62-65.
 
124
Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
RENARD P (a), KOVALSKI JL (b), COCHEREAU I (c), JAULERRY S (d), WILLIAMSON W (e), ELENA PP (f), LABLACHE COMBIER M (g), ALLAIRE C (g) AND SIOU-MERMET R (g).
Graefe's Arch. Clin. and Exp. Ophthalmol. 2005; 243: 1221-1227. ⇒ to read the abstract
(a) Institut Vernes, Paris, France - (b) HIA Clermont Tonnerre, Brest, France - (c) CHRU, Angers, France - (d) CH Tarbes Vic Bigorre, Tarbes, France - (e) CH François Mitterrand, Pau, France - (f) IRIS PHARMA-CLIROPHTHA, Nice, France - (g) BAUSCH & LOMB, Paris, France
 
123
Variation of krüppel-like factors ARNm levels in a mouse corneal model of angiogenesis.
CHIAMBARETTA F, NEZZAR H, FERAILLE L, DE GRAEVE F, MARCEAU G, ELENA PP, RIGAL D, DASTUGUE B AND SAPIN V
SFO meeting 2005; Paris – France. Abstract No. 380.
 
2004
122 Ocular hypotensive effect of a new “once-daily” eye-dops formulation of 0.5% timolol (Timolast™) in comparison to Timoptol® 0.5% administered twice-daily.
ROULAND JF (a), MOREL-MANDRINO P (b), ELENA PP (b), DE GREGORIO F (c), BAROZZI C (c), FEDELI E (c) AND FERREIRA VD (c).
ISOPT meeting 2004; Monte-Carlo – Monaco.
(a) Hôpital Huriez, Lille, France - (b) CLIROPHTHA, Nice, France - (c) TUBILUX PHARMA SpA, Roma, Italy

121
Intérêt d’une nouvelle formulation de diclofénac sans conservateur pour la surface oculaire.
CHIAMBARETTA F (a), CREUZOT-GARCHER C (b), PILON F (a), POULIQUEN P (c), REBIKA H (c), DUBRAY C (d) AND RIGAL D (a).
J. Fr. Ophtalmol. 2004; 27, 7, 739-744. (collaboration). ⇒ to read the article
(a) Hôpital Gabriel Montpied, Clermont-Ferrand, France - (b) CHU de Dijon, Dijon, France - (C) LABORATOIRES THEA, Clermont-Ferrand, France - (d) Unité de Pharmacologie Clinique, Centre de Recherche en Nutrition Humaine, Clermont-Ferrand, France

120
Comparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprost.
BRON A, VELASQUE L, REBICA H, POULIQUEN P, ELENA PP, AND ROULAND JF.
J. Fr. Ophtalmol. 2004; 27(9 Pt 1): 971-7. ⇒ to read the abstract
 
119
Non-inferiority, in the intra-ocular pressure (IOP)-lowering effect, of a new eye-drops formulation of 0.5% timolol (Timolast™) instilled once-daily versus 0.5% Timoptol®, instilled twice-daily, for 4 months in ocular hypertensive or glaucomatous patients.
ROULAND JF (a), MOREL-MANDRINO P (b), DE GREGORIO F (c), BAROZZI C (c), AND FEDELI E (c).
ARVO meeting 2004; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 2080.
(a) Hôpital Huriez, Lille, France - (b) CLIROPHTHA, Nice, France - (c) TUBILUX PHARMA SpA, Roma, Italy
 
118
Comparison of carteolol plasmatic levels after repeated instillations of long acting and regular formulations of carteolol 2% in glaucomatous patients.
ALLAIRE CM, RENARD P, KOVALSKI J, COCHEREAU I, JAULERRY S, WILLIAMSON W, ELENA PP AND LABLACHE-COMBIER M.
ARVO meeting 2004; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 957.
 
117
Efficacy and safety of diclofenac 0.1% ABAK® versus preserved diclofenac® 0.1% eye drops in controlling post-cataract surgery inflammation.
GOLDSCHMIDT P, ELENA PP, BALDWIN H, DELVAL L AND COLIN J.
ARVO meeting 2004; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 294.
 
116
PKC412 content in retina, choroid and plasma of pup mice with retinal neovascularization induced by hyperoxic stimuli.
ELENA PP (a), AMAR T (a), CAILLAUD T(a), WONG M (b) AND BIZEC JC (c).
ARVO meeting 2004; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 4053 ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France - (b) NOVARTIS PHARMA, East Hanover, USA - (C) NOVARTIS PHARMA AG, Basel, Switzerland

115
PKC412 reduces retinal neovascularization induced by hypoeroxic stimuli in pup mice.
CAILLAUD T (a), AMAR T (a), OTTLECZ A (b), WONG M (c), LAMBROU GN (b) AND ELENA PP (a).
ARVO meeting 2004; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2004; 45: ARVO e-abstract No. 4062. ⇒ to read the abstract
(a) IRIS PHARMA, Nice, France - (b) NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland - (c) NOVARTIS PHARMA, East Hanover, USA
 
2003
114
In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
CHABRY J (a), RATSIMANOHATRA C (b), SPONNE I (c), ELENA PP (b), VINCENT JP (a), PILLOT T (c).
J Neurosci. 2003 Jan 15; 23(2): 462-9. ⇒ to read the article
(a) Institut de Pharmacologie Moléculaire et Cellulaire 6097, Valbonne, France - (b) IRIS PHARMA, Nice, France - (c) Institut National de la Santé et de la Recherche Médicale, Vandœuvre-les-Nancy, France
2002
113
Potency and duration of action of synthetic P2Y2 receptor agonists on Schirmer scores in rabbits.
YERXA BR, DOUGLASS JG, ELENA PP, CAILLAUD T, AMAR T, REDICK CC AND PETERSON WM.
Adv. Exp. Med. Biol. 2002; 506: 261-265.
 
112
Timolol 0.1% Gel (Nyogel 0.1%®) Once Daily versus Conventional Timolol 0.5% Solution Twice Daily: A Comparison of Efficacy and Safety.
ROULAND JF (a), MOREL-MANDRINO P (b), ELENA PP (b), POLZER H (c) and SUNDER RAJ P (d).
Ophthalmologica 2002; 216: 449-454. ⇒ to read the abstract
(a) Hôpital Huriez, Lille, France - (b) CLIROPHTHA, Nice, France - (c) MEDPROJECT PHARMA, Sauerlach, Germany - (d) NOVARTIS OPHTHALMICS, Farnborough, UK
 
111
Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit.
TISSIE G (a), SEBASTIAN C (a), ELENA PP (b), DRIOT JY (a) AND TRINQUAND C (a).
J. Ocul. Pharmacol. Ther. 2002; 18: 65-73. ⇒ to read the abstract
(a) LABORATOIRE BAUSCH & LOMB/CHAUVIN, Montpellier, France - (b) IRIS PHARMA, Nice, France
 
2001
110
Topical ocular instillation of nitric oxide synthase inhibitors and intraocular pressure in rabbits.
FLEISCHHAUER JC (a) , LIU R (a) , ELENA PP (b), FLAMMER J (a) AND HAEFLIGER IO (a).
Klin. Monatsbl. Augenheidkd. 2001; 218: 351-353. ⇒ to read the abstract
(a) Laboratory of Ocular Pharmacology and Physiology, Basel, Switzerland - (b) IRIS PHARMA, Nice, France
 
109
A Novel Once-a-Day Timolol 0.1% Gel Formulation has an equivalent IOP-lowering efficacy to timolol 0.5% solution.
ROULAND JF (a), MOREL-MANDRINO P (b), ELENA PP (b) and POLZER H (c).
IGS meeting 2001; Prague - Czech Republic. ⇒ to read the abstract
(a) Hôpital Huriez, Lille, France - (b) CLIROPHTHA, Nice, France - (c) MEDPROJECT PHARMA, Sauerlach, Germany
 
108
Ocular distribution of CAT-152 after a single subconjunctival injection in a pigmented rabbit model of glaucoma filtration surgery.
ELENA PP, MCFARLANE S, GLOVER DR, AMAR T AND CAILLAUD T.
ARVO meeting 2001; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 2001; 42: S544, abstract No. 2915.
 
2000
107
A new long acting ophthalmic formulation of carteolol containing alginic acid.
SECHOY O, TISSIE G, SEBASTIAN C, MAURIN F, DRIOT JY AND TRINQUANT C.
Int. J. Pharm. 2000; 207: 109-116. (collaboration)
 
106
A new long acting ophthalmic formulation of carteolol containing alginic acid.
SECHOY O (a), TISSIE G (a), SEBASTIAN C (a), MAURIN F (a), DRIOT JY (a) AND TRINQUANT C (a).
Int. J. Pharm. 2000; 207: 109-116. (collaboration) ⇒ to read the abstract
(a) LABORATOIRE CHAUVIN, Montpellier, France
 
105
Therapeutic equivalence of a timolol 0.1% hydrogel (T-Gel 0.1%) QD and aqueous timolol 0.5% BID in reducting the IOP of glaucomatous patients.
ELENA PP, ROULAND JF, MOREL-MANDRINO P AND POLZER H.
ARVO meeting 2000; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 2000; 41: S281, abstract No. 2477.
 
104
Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension.
LACHERETZ F, BARBIER A, SERRADEIL-LE GAL C, ELENA PP, MAFFRAND J AND LE FUR G.
J. Ocul. Pharmacol. Ther. 2000; 16: 203-216. ⇒ to read the abstract
 
103
Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits.
PISELLA PJ (a,b), FILLACIER K (d), ELENA PP (e), DEBBASCH C (b,c) AND BAUDOUIN C (a).
Ophthalmic Res. 2000; 32: 3-8. ⇒ to read the article
(a) Department of Ophthalmology, Ambroise Paré Hospital, APHP, Paris, France - (b) Toxicology Laboratory, University of Paris-V René Descartes, Paris, France - (c) Department of Cellular Pharmacotoxicology, XV-XX Hospital, Paris, France - (d) Department of Ophthalmology, University of Nice, France - (e) IRIS PHARMA, Nice, France

102
Localisation of Venoruton in rat blood vessel after single oral administration.
SALLIN D, ELENA PP AND ZIJLSTRA J.
14th World Congress ot the 'Union Internationale de Phlebologie' Roma - Italy 2000.
 
101
Evaluation of a novel carteolol eye-drops with alginic acid as long action promoter.
TISSIE G, SEBASTIAN C, MAURIN F, SECHOY O, DRIOT JY, ELENA PP AND TRINQUAND C.
EVER meeting 2000; Palma de Mallorca, Spain. Ophthalmic Res. 2000; 32(S2): 29, abstract No. 214.
 
100
Alginic acid effect on ocular distribution of carteolol after a single instillation in pigmented rabbits.
SEBASTIAN C, TISSIE G, DRIOT JY, ELENA PP AND TRINQUAND C.
EVER meeting 2000; Palma de Mallorca, Spain. Ophthalmic Res. 2000; 32(S2): 28, abstract No. 215.
 
99
Potency and duration of action of synthetic P2Y2-receptor agonists on schirmer scores in rabbits.
YERXA BR, DOUGLASS JG, ELENA PP, CAILLAUD T, AMAR T AND PETERSON WM.
(3rd International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes Maui, HI - USA) Cornea 2000; 19: S138.
 
98
Ethics committee recommendations for laboratory animals in private research in France.
B. VERSCHUERE B, AUTISSIER C, DEGRYSE AD, GALLIX P, GOTTI B, LAURENT J, LEINOT M AND PEYCLIT I.
Laboratory Animals 2000; 34: 236-243. ⇒ to read the article (collaboration)
 
1999
97
Benefits of a vasopressin V2 receptor antagonist, SR 121463, in the treatment of ocular hypertension in the rabbit.
SERRADEIL-LE GAL C, LACHERETZ F, BARBIER A, ELENA PP, PASCAL M, MAFFRAND JP AND LE FUR G.
World Congress on Neurohypophysial Hormones. 1999; Edinburgh - UK.
 
96
INS365, a P2Y2 receptor agonist, increases Schirmer scores in albino rabbits.
YERXA BR, ELENA PP, CAILLAUD T, AMAR T AND EVANS R.
ARVO meeting 1999; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1999; 40: S540, abstract No. 2848.
 
1998
95
Inflammation measurement and immunocharacterization of cell proliferation in an experimental model of proliferative vitreoretinopathy.
BAUDOUIN C, KHOSRAVI E, PISELLA PJ, ETTAICHE M AND ELENA PP.
Ophthalmic Res. 1998; 30: 340-350. ⇒ to read the abstract
 
94
The effect of pneumoperitoneum on intraocular pressure in rabbits with α-chymotrypsin-induced glaucoma.
LENTSCHENER C, LEVEQUE JP, MAZOIT JX AND BENHAMOU D.
Anesth. Analg. 1998; 86: 1283-1288. (collaboration)
 
93
Activity of SR121463, a selective non-peptide vasopressine V2 receptor antagonist, in a rabbit model of glaucoma.
LACHERETZ F, BARBIER A, SERRADEIL-LE GAL C, ELENA PP, MAFFRAND JP AND LE FUR G.
(ISER 1998 Abstract No. 795; Paris - France) Exp. Eye Res. 1998; 67: S239.
 
92
Protective effect of nicardipine, a calcium channel blocker on electroretinogram and retinal cytoskeletal damages after ischemia-reperfusion on the rat.
FREDJ-REYGROBELLET D, CAILLAUD T AND ELENA PP.
ARVO meeting 1998; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1998; 39: S993, abstract No. 4591.
 
91
Comparison of efficacy between ketotifen and olopatadine eyedrops in allergic conjunctivitis.
ELENA PP, AMAR T, FETZ A AND SCHOCH C.
ARVO meeting 1998; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1998; 39: S549, abstract No. 2531.
 
1997
90
Ocular distribution of lomefloxacin 0.3 % after a single instillation in the infected eye of pigmented rabbits.
ELENA PP AND JAUCH A.
J. Ocul. Pharmacol. Ther. 1997; 13: 551-558. ⇒ to read the abstract
 
89
Intraocular pressure effects of topical rilmenidine in ocular hypertensive animals and in healthy volunteers and glaucoma subjects.
NORDMANN JP, ELENA PP AND VILAIN C.
ISECOPP meeting 1997 Munich – Germany, p. 12.
 
88
Efficacy and local ocular tolerance of Rescula eye drops in glaucoma patients.
NORDMANN JP, ROULAND JF, ELENA PP AND KAPOK B.
ISECOPP meeting 1997 Munich – Germany, p. 27.
 
87
Analyse de l'inflammation et de la prolifération cellulaire intra-oculaires dans un modèle expérimental de prolifération vitréorétinienne.
PISELLA PJ, BECQUET F, ELENA PP AND BAUDOUIN C.
Ophtalmologie (France) 1997; 11: 369-371.
 
86
Effects of different formulations of mitoxantrone (solutions, nanospheres, liposomes) on glaucoma surgery in rabbits.
TILLEUL P, DENIS P, MAIGNEN F, ELENA PP, NORDMANN JP, LEVERGE R AND ROSTENE W.
Ophthalmic Res. 1997; 29: 218-226. ⇒ to read the abstract
 
85
Retinal damage and protection after ischemic injury in the rat: a reappraisal.
ELENA PP, CAILLAUD T, AMAR T AND HARITON C.
ARVO meeting 1997; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1997; 38: S888, abstract No. 4151.
 
84
Ocular distribution of Rescula® Eye-Drops in the pigmented rabbit after a single topical administration.
CAILLAUD T, AMAR T, HARITON C AND ELENA PP.
ARVO meeting 1997; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1997; 38: S815, abstract No. 3796.
 
83
Rilmenidine: effect on intraocular pressure in alpha-chymotrypsin rabbits.
AMAR T, NORDMANN JP, CASTAGNE I, VILAIN C AND ELENA PP.
ARVO meeting 1997; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1997; 38: S814, abstract No. 3790.
 
82
Rilmenidine : safety and efficacy on intraocular pressure in healthy volunteers and glaucoma patients.
NORDMANN JP, ELENA PP, MOREL-MANDRINO P, CASTAGNE I AND VILAIN C.
ARVO meeting 1997; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 1997;38 : S559, abstract No. 2600.
 
81
Protection induced by isopropyl unoprostone treatment after retinal ischemic injury in the rat.
MOREL-MANDRINO P, CAILLAUD T, ELENA PP AND HARITON C.
ARVO meeting 1997; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1997; 38: S103, abstract No. 502.
 
1996
80
Antiproliferative activity of a liposomal delivery system of mitoxantrone on rabbit subconjunctival fibroblasts in an ex-vivo model.
MAIGNEN F, TILLEUL P, BILLARDON C, XU-VAN OPSTAL WY, PELAPRAT D, ELENA PP, DENIS P AND ROSTENE W.
J. Ocul. Pharmacol. Ther. 1996; 12: 289-298.
 
79
The renin-angiotensin system in the rabbit eye.
RAMIREZ M, DAVIDSON EA, LUTTENAUER L, ELENA PP, CUMIN F, MATHIS GA AND DE GASPARO M.
J. Ocul. Pharmacol. Ther. 1996; 12: 299-312.
 
78
Histological and cytological retinal changes after pressure-induced ischemia in rat eye.
FREDJ-REYGROBELLET D, TABIASCO J, BALAS D, DENIS P AND ELENA PP.
(JERMOV 1996 Abstract No. 399; Montpellier - France) Vision Res. 1996; 36: S220.
 
77
Pharmacokinetics of 0.1 % azelastine eyedrops, a histamine-H1-antagonist, with or without an induced allergic conjunctivitis.
ELENA PP, KHOSRAVI E, BORBE H, HERBST M AND PETER G.
ARVO meeting 1996; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1996; 37: S1027, abstract No. 4719.
 
76
Inflammation measurement and immunocharacterization of cell proliferation in experimental PVR.
BAUDOUIN C, PISELLA PJ, KHOSRAVI E, ETTAICHE M AND ELENA PP.
ARVO meeting 1996; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1996; 37: S391, abstract No. 1808.
 
75
Assessment of the safety and local pharmacokinetics of 0.15 % gel of ganciclovir (Virgan®) in healthy volunteers.
ARVO meeting 1996; Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 1996; 37: S313, abstract No. 1431.
POULIQUEN P(a), ELENA PP(b), MALECAZE F(c), LUYCKX J(a), LANOUE A(a) AND GOLDSCHMIDT P(d).
(a) LABORATOIRES THEA, Clermont-Ferrand, France - (b) CLIROPHTHA, Nice, France - (c) Hôpital Purpan, Toulouse, France - (d) Centre Hospitalier Universitaire de la Pitié-Salpêtrière, Paris, France
 
74
Ocular bioavailability of ganciclovir gel, an anti-herpetic formulation, after topical administration to intact or removed corneal epithelium of rabbit eyes.
KHOSRAVI E, ELENA PP, GOLDSCHMIDT P AND LUYCKX J.
ARVO meeting 1996; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1996; 37: S81, abstract No. 383.
 
1995
73
Allergic conjunctivitis and uveitis models: Reappraisal with some marketed drugs.
KHOSRAVI E, ELENA PP AND HARITON C.
Inflamm. Res. 1995; 44: 47-54. ⇒ to read the abstract
 
72
Intraocular pressure effects of topical renin inhibitor CGP 38560 in normal and ocular hypertensive animals and in healthy volunteers and glaucoma subjects.
NORDMANN JP, PERCICOT CL, ELENA PP AND MATHIS GA.
ISECOPP meeting 1995; Geneva – Switzerland, p. 35.
 
71
One drop study to evaluate safety and efficacy of SR43845, a renin inhibitor, in healthy volunteers.
DENIS P, NORDMANN JP, ELENA PP, JAILLON P, MATHIS G AND SARAUX H.
ARVO meeting 1995, Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 1995; 36: S734, abstract No. 3388.
 
70
Evaluation of safety and efficacy of CGP38560, a renin inhibitor, in healthy volunteers and glaucoma subjects.
NORDMANN JP, DENIS P, ELENA PP, MATHIS GA, SCHNARR KD, TETZLOFF W AND KERKMANN T.
ARVO meeting 1995, Fort Lauderdale, FL – USA. Invest. Ophthalmol. Vis. Sci. 1995; 36: S719, abstract No. 3317.
 
69
Lomefloxacin distribution after a single instillation in the infected eye of pigmented rabbits.
KHOSRAVI E, ELENA PP AND JAUCH A.
ISECOPP meeting 1995 Geneva - Switzerland, p. 67.
 
68
Non-invasive measurement of ocular temperature by using infrared thermographic analysis in immune and non-immune allergy models.
ELENA PP, KHOSRAVI E AND HARITON C.
ISECOPP meeting 1995 Geneva - Switzerland, p. 60.
 
67
The renin angiotensin system in the rabbit eye.
RAMIREZ M, DAVIDSON EA, ELENA PP, MATHIS GA AND DE GASPARO M.
ISECOPP meeting 1995 Geneva - Switzerland, p. 25.
 
66
Lack of cytotoxic effect of ganciclovir and acyclovir on rabbit corneal epithelial cells in vitro.
KHOSRAVI E, ELENA PP, GOLDSCHMIDT P, BAUDOUIN C AND LUYCKX J.
JERMOV meeting 1995; Montpellier - France. Vision Res. 1995; 35: S173, abstract No. P125.
 
65
Dimethindene maleate in allergic conjunctivitis: a new indication for an old drug.
ELENA PP, KHOSRAVI E AND HARITON C.
ARVO meeting 1995; Fort Lauderdale, FL - USA. Invest. Ophthalmol. Vis. Sci. 1995; 36: S1014, abstract No. 4699.
 
1994
64
Central nervous system control of intraocular pressure.
DENIS P (a), NORDMANN JP (a), ELENA PP (b), SARAUX H (a) AND LAPALUS P (c).
Fundam. Clin. Pharmacol. (France) 1994; 8: 230-237. ⇒ to read the abstract
(a) Hôpital Saint-Antoine, dep. ophthalmology, Paris, France - (b) IRIS PHARMA, Nice, France - (c) School medicine, dep. pharmacology, Nice, France
 
63
Correlation between anterior chamber inflammation and proliferative vitreoretinopathy in the rabbit.
KHOSRAVI E, BAUDOUIN C AND ELENA PP.
JERMOV meeting 1994; Montpellier - France, p 240, abstract No. P192.
 
62
Ocular distribution of nicergoline after intravenous administration in rats.
ELENA PP, BERTHOLOM N AND KHOSRAVI E.
JERMOV meeting 1994; Montpellier - France, p 173, abstract No. P12.
 
61
Topical sodium sucrose octasulphate reduces corneal lesions in a keratoconjunctivitis sicca model in the rat.
CHIBRET H, ELENA PP, KHOSRAVI E, AND FREDJ-REYGROBELLET D.
ARVO meeting 1994; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1994; 35: 1693, abstract No. 2039.
 
60
Distribution of ganciclovir in the anterior uvea after topical application of 0.15 % ganciclovir gel to intact and HSV-infected eyes of rabbits.
ELENA PP, GOLDSCHMIDT P, CHAST F, SAUVAGEON H, LUYCKX J AND KHOSRAVI E.
ARVO meeting 1994; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1994; 35: 1682, abstract No. 1984.
 
59
Central nervous system control of intraocular pressure.
DENIS P (a), NORDMANN JP (a), ELENA PP (b), SARAUX H (a) AND LAPALUS P(c).
Fundam. Clin. Pharmacol. (France) 1994; 8: 230-237. ⇒ to read the abstract
(a) Hôpital Saint-Antoine, dep. ophthalmology, Paris, France - (b) IRIS PHARMA, Nice, France - (c) School medicine, dep. pharmacology, Nice, France
 
58
Angiotensin-II antagonists reduce intraocular pressure by a combined effect on aqueous humor synthesis and outflow.
MATHIS GA, PERCICOT C, MERMOUD A AND ELENA PP.
ARVO meeting 1994; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1994; 35; 1483, abstract No. 1060.
 
1993
57
Physiological roles of dopamine and neuropeptides in the retina.
DENIS P, NORDMANN JP, ELENA PP, DUSSAILLANT M, SARAUX H AND LAPALUS P.
Fundam. Clin. Pharmacol. (France) 1993; 7: 293-304.
 
56
Bioequivalence between timolol maleate formulated in ophthalmic solution (Timoptol®) and in a novel gel vehicle (T-Gel).
ELENA PP, POLZER H AND KHOSRAVI E.
ARVO meeting 1993; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1993; 34: 1490, abstract No. 3902.
 
55
Ocular pharmacokinetics of topically-applied ganciclovir in rabbits with intact or removed corneal epithelium.
CHIBRET H, ELENA PP AND KHOSRAVI E.
ARVO meeting 1993; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1993; 34: 1050, abstract No. 1712.
 
54
Mifepristone (RU 486): in vitro binding to glucocorticoid receptors in iris-ciliary body and in vivo effects on intraocular pressure in rabbits.
DENIS P, ELENA PP, NORDMANN JP, SARRIEAU A, SARAUX H AND ROSTENE W.
ARVO meeting 1993; Sarasota, FL - USA. Invest. Ophthalmol. Vis. Sci. 1993; 34: 925, abstract No. 1115.
 
53
Piribédil: affinité pour les récepteurs dopaminergiques rétiniens et profil pharmacocinétique oculaire.
LAPALUS P (a), DENIS P (b), DRICI M (a), FREDJ-REYGROBELLET D (a) AND ELENA PP (c).
J. Neur. 1993; 240 (Suppl 1): S17-S21. ⇒ to read the abstract
(a) School medicine, dep. pharmacology, Nice, France - (b) Hôpital Saint-Antoine, Paris, France - (c) IRIS PHARMA, Nice, France
 
1992
52
Retinal dopaminergic receptor affinity and ocular pharmacokinetic profile of piribedil.
LAPALUS P, DENIS P, DRICI M, FREDJ-REYGROBELLET D AND ELENA PP.
J. Neurol. 1992; 239 (Suppl 1): S17-S21. ⇒ to read the abstract
 
51
Ocular pharmacokinetics of trimetazidine in the pigmented rat after a single oral administration.
ELENA PP, KHOSRAVI E, LAPALUS P, JOULIN Y AND HARPEY C.
ISER meeting 1992; Stresa - Italy. Exp. Eye Res. 1992; 55: S55, abstract No. 184.
 
50
Effect of diclofenac sodium and diclofenac sodium SDU eyedrops on prostaglandin concentrations in aqueous humor of rabbits after extracapsular surgery.
ELENA PP, ULRICH E, TSCHALÄR Y, LAPALUS P, ETTAICHE M AND KHOSRAVI E.
ISER meeting 1992; Stresa - Italy. Exp. Eye Res. 1992; 55: S54, abstract No. 183.
 
49
Ocular pharmacokinetics of two preservatives, benzalkonium chloride or benzoxonium chloride, after instillation in the pigmented rabbit.
ELENA PP, KHOSRAVI E, LAPALUS P AND ULRICH E.
ISER meeting 1992; Stresa - Italy. Exp. Eye Res. 1992; 55: S54, abstract No. 182.
 
48
Preclinical pharmacokinetics of the 14C-labelled aldose reductase inhibitor methosorbinil (E-0722).
ELENA PP, KUNZ PA AND LAPALUS P.
SOE meeting 1992, Brussels - Belgium, p. 188, abstract No. 737.
 
1991
47
La radioautographie en ophtalmologie: méthodologie et applications à l'étude des récepteurs oculaires et à l'hybridation in situ.
DENIS P, ELENA PP, NORDMANN JP, DUSSAILLANT M, LAPALUS P, SARAUX H AND ROSTENE W.
"Physiologie, Pathologie et Génétique Oculaire." CHRISTEN Y AND DROIX-LEFAIX MT ed. (Springer Verlag, Paris, 1991), 105-113.
 
46
LAPALUS P, ELENA PP, NORDMANN JP, LAROCHE L, SARAUX H AND LAPALUS P.
Localisation et caractérisation radioautographiques des récepteurs β-adrénergiques oculaires dans les structures non pigmentées chez l'homme.
Ophtalmologie (France) 1991; 5: 53-56.
 
45
Localization and characterization of substance P binding sites in rat and rabbit eyes.
DENIS P, FARDIN V, NORDMANN JP, ELENA PP, LAROCHE L, SARAUX H AND ROSTENE W.
Invest. Ophthalmol. Vis. Sci. 1991; 32: 1894-1902. ⇒ to read the article
 
44
Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes.
DENIS P, DUSSAILLANT M, NORDMANN JP, ELENA PP, SARAUX H AND ROSTENE W.
Exp. Eye Res. 1991; 52: 357-366.
 
43
Autoradiographic localization of β-adrenergic binding sites in human retinal blood vessels.
DENIS P, ELENA PP AND LAPALUS P.
Chibret Int. J. 1991; 7: 14-19.
 
42
Distribution rétinienne des sites récepteurs dopaminergiques rétiniens chez l'homme. Hypothèses fonctionnelles sur le rôle de la dopamine dans la vision.
DENIS P, NORDMANN JP, ELENA PP AND LAPALUS P.
(Dopamine, Fonctions Cérébrales et Neurosensorielles; Budapest - Hungary 1991) Euthérapie.
 
1990
41
Autoradiographic localization of D1 and D2 dopamine binding sites in the human retina.
DENIS P, ELENA PP, NORDMANN JP, SARAUX H AND LAPALUS P.
Neurosci. Lett. 1990; 116: 81-86.
 
40
ß-adrenergic binding sites in the human eye: an autoradiographic study.
ELENA PP, DENIS P, KOSINA-BOIX M, SARAUX H AND LAPALUS P.
J. Ocul. Pharmacol. 1990; 6: 143-149.
 
39
Localisation et caractérisation autoradiographiques de sites de liaison oculaires du VIP (Vasoactive Intestinal Peptide) chez le rat et le lapin albinos.
DENIS P, DUSSAILLANT M, ELENA PP, NORDMANN JP, ROSTENE W AND LAROCHE L.
Ophtalmologie (France) 1990; 4: 30-32.
 
38
Cytotoxicity studies in ophthalmology.
LAPALUS P, ETTAICHE M, FREDJ-REYGROBELLET D, JAMBOU D AND ELENA PP.
Lens Eye Toxic Res. 1990; 7: 231-242.
 
37
Ocular pharmacokinetics of ganciclovir gel after a single administration.
LAPALUS P, ETTAICHE M, LUYCKX J AND ELENA PP.
AER meeting 1990, Bad Honnef - Germany, p 58, abstract No. 94.
 
36
Hymecel pharmacokinetics after a single intracameral injection in phakic and aphakic eyes of pigmented rabbits.
ELENA PP, LAPALUS P, FREDJ-REYGROBELLET D, ETTAICHE M AND ULRICH E.
AER meeting 1990, Bad Honnef - Germany, p 25, abstract No. 6.
 
35
Specific receptors to vasculotropin in the eye.
MOUKADIRI H, DENIS P, ELENA PP, ROSTENE W AND PLOUET J.
AER meeting 1990, Bad Honnef - Germany, p 24, abstract No. 4.
 
34
Localization and characterization of receptors in human and animal eyes by “ in vitro ” autoradiography.
ELENA PP, DENIS P, FREDJ-REYGROBELLET D, ROSTENE W AND LAPALUS P.
ISER meeting 1990; Helsinki - Finland, p 228, abstract No. 803.
 
33
Autoradiographic localisation of insuling binding sites in the human eye.
DENIS P, ELENA PP, LE MARCHAND-BRUSTEL Y, NORDMANN JP, LAPALUS P AND SARAUX H.
ISER meeting 1990; Helsinki - Finland, p 114, abstract No. 384.
 
32
Retinal dopaminergic receptors and distribution of piribedil.
LAPALUS P, ELENA PP, FREDJ-REYGROBELLET D AND DENIS P.
ENS meeting 1990, Brighton - UK.
 
31
Localisation et caractérisation radioautographiques des récepteurs ß-adrénergiques oculaires dans les structures non pigmentées chez l'homme.
DENIS P, ELENA PP, NORDMANN JP, SARAUX H AND LAPALUS P.
SFO meeting 1990, Paris - France.
 
30
La radioautographie en ophtalmologie: méthodologie et applications à l'étude des récepteurs oculaires et à l'hybridation in situ.
DENIS P, ELENA PP, NORDMANN JP, LAPALUS P AND SARAUX H.
Séminaires Ophtalmologiques IPSEN, Royaumont - France 1990.
 
1989
29
Pharmacokinetic and autoradiographic studies of basic fibroblast growth factor on de-epithelialized and intact rabbit eye.
FREDJ-REYGROBELLET D, ELENA PP, MOENNER M, BAUDOUIN C, ETTAICHE M, BARRITAULT D AND LAPALUS P.
Curr. Eye Res. 1989; 8: 1141-1152.
 
28
Localisation autoradiographique des récepteurs dopaminergiques rétiniens chez l'homme. Implications fonctionnelles.
DENIS P, NORDMANN JP, ELENA PP, LAROCHE L AND LAPALUS P.
Bull. Soc. Ophtalmol. Fr. (France) 1989; 89: 807-810.
 
27
Récepteurs béta-adrenergiques vasculaires rétiniens chez l'homme.
DENIS P AND ELENA PP.
Ophtalmologie (France) 1989; 3: 62-64. ⇒ to read the abstract
 
26
Dopamine receptors in rabbit and rat eye: characterization and localization of DA1 and DA2 binding sites.
ELENA PP, DENIS P, KOSINA-BOIX M AND LAPALUS P.
Curr. Eye Res. 1989; 8: 75-83.
 
25
Alpha2-adrenergic receptors in rat and rabbit eye: a tritium-sensitive film autoradiography.
ELENA PP, KOSINA-BOIX M, DENIS P, MOULIN G AND LAPALUS P.
Ophthalmic Res. 1989; 21: 309-314. ⇒ to read the abstract
 
24
Localisation of angiotensin-converting enzyme (ACE) in rat ciliary process by autoradiography and immunocytochemistry.
LALIBERTE F, ELENA PP, LALIBERTE MF, LAPALUS P AND CHEVILLARD C.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 194-195, abstract No. 167.
 
23
Beta-adrenergic receptors in human eye sections.
ELENA PP, DENIS P, LAROCHE L, AND LAPALUS P.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 194, abstract No. 166.
 
22
Autoradiographic localization of vasoactive intestinal peptide binding sites in albino rabbit and rat eye.
DENIS P, DUSSAILLANT M, NORDMANN JP, ELENA PP, ROSTENE W AND SARAUX H.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 159-160, abstract No. 104.
21
Autoradiographic localisation of insulin receptors in the human eye.
ELENA PP, DENIS P, LE MARCHAND-BRUSTEL Y AND LAPALUS P.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 158-159, abstract No. 102.
 
20
Pharmacokinetics of topically-administered aldose reductase inhibitor (E-0722) on pigmented rabbit eye.
LAPALUS P, FREDJ-REYGROBELLET D AND ELENA PP.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 129-130, abstract No. 45.
 
19
Pharmacokinetic and autoradiographic studies of basic fibroblast growth factor on de-epithelialised and intact rabbit eye.
FREDJ-REYGROBELLET D, ELENA PP, MOENNER M, BAUDOUIN C, ETTAICHE M, BARRITAULT D AND LAPALUS P.
AER meeting 1989, Montpellier - France, Doc. Ophthalmol. 1990; 76: 111, abstract No. 13.
 
18
Piribedil and retinal dopaminergic binding sites.
LAPALUS P, ELENA PP, DENIS P AND FREDJ-REYGROBELLET D.
World Congress of Neurology 1989, New Dehli - India.
 
17
Localisation autoradiographique des récepteurs dopaminergiques rétiniens chez l'homme. Implications fonctionnelles.
DENIS P, NORDMANN JP, ELENA PP, LAROCHE L AND LAPALUS P.
SFO meeting 1989, Paris - France.
 
1988
16
Neurotransmitters and intraocular pressure.
LAPALUS P AND ELENA PP.
Fundam. Clin. Pharmacol. (France) 1988; 2: 305-325.
 
15
Autoradiographic localization of beta-adrenergic binding sites in human blood retinal vessels.
ELENA PP, DENIS P AND LAPALUS P.
ISER meeting 1988, San Francisco, CA - USA.
 
14
Autoradiographic characterization of D-1 and D-2 receptors in rat, rabbit and human Eyes.
ELENA PP, DENIS P AND LAPALUS P.
ISER meeting 1988, San Francisco, CA - USA.
 
1987
13
Autoradiographic localization of ß-adrenergic receptors in rabbit eye.
ELENA PP (a), KOSINA-BOIX M (b), MOULIN G (a) AND LAPALUS P (b).
Invest. Ophthalmol. Vis. Sci. 1987; 28: 1436-1441. ⇒ To read the article
(a) LABORATOIRE DULCIS ALLERGAN, Monaco - (b) Laboratoire de Pharmacologie, Faculte de Medecine, Nice, France

12
Dopamine DA1 receptors in the eye: characterization and localization of 125I-SCH 23982 binding sites.
ELENA PP, KOSINA-BOIX M, AND LAPALUS P.
AER meeting 1987, Leuven - Belgium.
 
1986
11
Effects of a new anti-allergic agent: the magnesium salt of N-Acetyl-Aspartyl-Glutamic Acid on experimental allergic inflammation of the rabbit eye.
LAPALUS P, MOULIN G, BAYER V, FREDJ-REYGROBELLET D AND ELENA PP.
Curr. Eye Res. 1986; 5: 517-522.
 
10
Monoclonal antibodies to human amnion recognize different components of the rabbit eye.
HSI BL, FREDJ-REYGROBELLET D, YEH CJG, ELENA PP, MOULIN G AND LAPALUS P.
Invest. Ophthalmol. Vis. Sci. 1986; 27: 620-622. ⇒ to read the article
 
9
Système alpha-adrenergique et pression intra-oculaire.
LAPALUS P AND ELENA PP.
Rencontres Internationales de Chimie Thérapeutique, Clermont-Ferrand - France 1986.
 
8
Autoradiographic localization of ß-adrenergic receptors in rabbit eye.
ELENA PP, KOSINA-BOIX M, MOULIN G AND LAPALUS P.
AER meeting 1986, Oxford - UK.
 
1985
7
Embryological studies of rabbit eye by using monoclonal antibodies.
FREDJ-REYGROBELLET D, HSI BL, MOULIN G, YEH CJG, ELENA PP AND LAPALUS P.
AER meeting 1985, Leyzin - Switzerland, p 61 abstract No. 73.
 
6
Alpha-adrenoceptors in rabbit iris-ciliary-body (ICB) membranes: characterization and localization with 3H-clonidine.
ELENA PP, PALTRINIERI P, MOULIN G, FREDJ-REYGROBELLET D AND LAPALUS P.
AER meeting 1985, Leyzin - Switzerland, p 5.
 
1984
5
Pharmacological characteristics of β-adrenergic-sensitive adenylate cyclase in non pigmented and pigmented cells of bovine ciliary process.
ELENA PP, FREDJ-REYGROBELLET D, MOULIN G AND LAPALUS P.
Curr. Eye Res. 1984; 3: 1383-1389.
 
4
Characterization of β-adrenergic receptors in bovine pigmented ciliary processes.
ELENA PP, MOULIN G AND LAPALUS P.
Curr. Eye Res. 1984; 3: 743-750. ⇒ to read the abstract
 
3
Etude cinétique d'un anti-allergique, le 14C-T86 en instillation chez le lapin albinos.
LAPALUS P, MOULIN G, BAYER V, ELENA PP, NICOLAS C AND LAPALUS F.
J. Biophys. Med. Nucl. 1984; 8: 195-198.
 
2
Etude cinétique d'un anti-allergique, le 14C-T86, en instillation chez le lapin albinos.
LAPALUS P, MOULIN G, BAYER V, ELENA PP, NICOLAS C AND LAPALUS F.
Congrès de Médecine Nucléaire de Langue Francaise; Nice - France 1984.
 
1
Adenylate cyclase activity in non pigmented (NPE) and in pigmented (PE) cells of bovine ciliary process.
ELENA PP, FREDJ-REYGROBELLET D, MOULIN G AND LAPALUS P.
ISER meeting 1984, Alicante - Spain, p 95.
 
 
ABBREVIATIONS
ARVO Association for Research in Vision and Ophthalmology
ATERET Association Tunisienne d’Etude et de Recherche sur les Eléments Trace
ECLSO European Contact Lens Society of Ophthalmologists
EVER European Vision and Eye Research
IGS International Glaucoma Symposium
ISECOPP International Symposium on Experimental and Clinical Ocular Pharmacology and Pharmaceutics
ISOPT International Symposium on Ocular Pharmacology and Therapeutics
MCLOSA Medical Contact Lens and Ocular Surface Association
SAFIR Société de l'Association Française des Implants et de la chirurgie Réfractive
SFERETE Société Francophone d'Etude et de Recherche sur les Eléments Traces Toxiques et Essentiels
SFO

Société Française d'Ophtalmologie

SFVB Société Francophone Vitamines et Biofacteurs
STO Société Tunisienne d'Ophtalmologie